A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
A study co-led by Columbia scientists suggests a nutrient transporter located at the blood-brain barrier could be commandeered to sneak therapeutic drugs into the brain.
The Afternoon of Science series at the Vagelos College of Physicians and Surgeons continued Feb. 5 with presentations from Department of Biochemistry & Molecular Biophysics faculty.
The Afternoon of Science series at the Vagelos College of Physicians and Surgeons continued Nov. 16 with presentations from Department of Microbiology & Immunology faculty members.
Several faculty members from the VP&S Department of Physiology & Cellular Biophysics gave presentations at the latest in the medical school’s Afternoon of Science series.
Iok In Christine Chio, PhD, and Oliver Clarke, PhD, early-career investigators at VP&S, are 2023 recipients of prestigious awards from the Irma T. Hirschl Trust Research Scientist Program.
